Promising early research on astaxanthin looks toward a slew of new health areas.
The seemingly endless relationship between bacteria and good health hints at just how limitless a future probiotic market could be.
Frutarom’s Portusana purslane extract was found to significantly reduce systolic blood pressure and HbA1c, a marker of blood glucose control, in a new human clinical trial.
The newly authorized claim says replacing sugars with inulin “induces a lower blood glucose rise after their consumption compared to sugar-containing foods/drinks.”
Participants consuming Coleus forskohlii extract for 12 weeks showed favorable improvements to insulin concentration and insulin resistance compared to a placebo group.
“Metabolic Synergizer” Is a New Category in Dietary Supplements, Firm Says, and It’s Not Weight Management
While OmniLean provides weight-loss benefits, OmniActive Health says it is not calling this a weight-management ingredient.
A new clinical trial of Vinia, a red grape powder product from BioHarvest (Rehovot, Israel), suggests it may offer benefits to patients with type 2 diabetes.
Researchers observed improvements to metabolism, blood sugar, and appetite control after just three days of participants consuming bread made from barley kernels.
Researchers found Kamut khorasan wheat produced significant improvements to key blood markers in type 2 diabetes patients.
Steviva says the “single-location sourcing ensures dependable, consistent flavor” of its new BraziliaSweet RA95 and BraziliaSweet 95–60 stevia extracts.